Intervention Protocol

You have free access to this content

Anterior approach versus conventional liver resection for hepatocellular carcinoma

  1. Quan Wang,
  2. Bobo Zheng,
  3. Bin Ma,
  4. KeHu Yang*

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 31 MAY 2013

DOI: 10.1002/14651858.CD010545


How to Cite

Wang Q, Zheng B, Ma B, Yang K. Anterior approach versus conventional liver resection for hepatocellular carcinoma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD010545. DOI: 10.1002/14651858.CD010545.

Author Information

  1. Lanzhou University, Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou City, China

*KeHu Yang, Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou City, China. yangkh@lzu.edu.cn. Yangkh2006@163.com.

Publication History

  1. Publication Status: New
  2. Published Online: 31 MAY 2013

SEARCH

References

Additional references

Abrishami 2008
  • Abrishami A, Nasseri-Moghaddam S, Eghtesad B, Sherman M. Surgical resection for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006935]
Aguilar 1993
  • Aguilar F, Hussain S, Cerutti P. Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proceedings of the National Academy of Sciences of the United States of America 1993;90(18):8586-90.
Bosch 2004
Brok 2008
  • Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61(8):763–9.
Brok 2009
  • Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive - Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology 2009;38(1):287-98.
Capussotti 2012
  • Capussotti L, Ferrero A, Russolillo N, Langella S, Lo Tesoriere R, Viganò L. Routine anterior approach during right hepatectomy: results of a prospective randomised controlled trial. Journal of Gastrointestinal Surgery 2012;16:1324–32.
CTU 2011
  • Copenhagen Trial Unit. TSA - Trial Sequential Analysis. http://ctu.dk/tsa/ (accessed 12 April 2013).
DeMets 1987
DerSimonian 1986
Egger 1997
  • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315:629-34.
Fattovich 2004
Fortner 1978
Galandi 2004
  • Galandi D, Antes G. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD003046.pub2]
Gluud 2013
  • Gluud C, Nikolova D, Klingenberg SL, Alexakis N, Als-Nielsen B, Colli A, et al. Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2013, Issue 3. Art. No.: LIVER.
Grasso 2000
  • Grasso A, Watkinson AF, Tibballs JM, Burroughs AK. Radiofrequency ablation in the treatment of hepatocellular carcinoma - a clinical viewpoint. Journal of Hepatology 2000;33:667-72.
Guiteau 2010
Higgins 2008
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hollis 1999
  • Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ (Clinical Research Ed.) 1999;319:670-4.
Ibrahim 2006
Jacobs 2006
  • Jacobs JP,  Mavroudis C,  Jacobs ML,  Maruszewski B,  Tchervenkov CI,  Lacour-Gayet FG,  et al. What is operative mortality? Defining death in a surgical registry database: a report of the STS Congenital Database Taskforce and the Joint EACTS-STS Congenital Database Committee. Annals of Thoracic Surgery 2006;81(5):1937-41.
Johnson 2002
Karnofsky 1948
Karnofsky 1949
  • Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949:191-205.
Kim 2006
Kjaergard 2001
  • Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
Kumar 2007
  • Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. Journal of Gastroenterology and Hepatology 2007;22(7):1104-11.
Lai 1996
  • Lai EC, Fan ST, Lo CM, Chu KM, Liu CL. Anterior approach for difficult major right hepatectomy. World Journal of Surgery 1996;20(3):314-7; discussion 318.
Lee 1982
  • Lee NW, Wong J, Ong GB. The surgical management of primary carcinoma of the liver. World Journal of Surgery 1982;6:66-75.
Liu 2000
Liu 2006
  • Liu CL, Fan ST, Cheung ST, Lo CM, Ng IO, Wong J. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Annals of Surgery 2006;244:194-203.
Llovet 1999
Llovet 2003
Llovet 2005
Lundh 2012
Macaskill 2001
Matsumata 1993
Mavroudis 2000
  • Mavroudis C, Jacobs JP, eds. Congenital Heart Surgery Nomenclature and Database Project. Annals of Thoracic Surgery 2000;69(Suppl 1):S1-S372. [DOI: 10.1016/S0003-4975(99)01278-3]
Mazzaferro 1996
  • Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New England Journal of Medicine 1996;334:693-9.
Moher 1998
  • Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
Murray 1997
Okuda 1985
Oliveri 2012
  • Oliveri RS,  Wetterslev J,  Gluud C. Hepatocellular carcinoma. Lancet 2012;380(9840):470.
Ozawa K 1990
Parkin 1999
Parmar 1998
RevMan 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Royle 2003
  • Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 1995;332:1685-90.
Savovic 2012
  • Savovic J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment 2012;16(35):1-82.
Savovic 2012a
  • Savovic J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012;157(6):429-38.
Schoppmeyer 2009
Schulz 1995
  • Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
Schwartz 1984
Schünemann 2009
  • Schünemann H,  Brożek J,  Oxman A,  editors. GRADE handbook for grading quality of evidence and strength of recommendation. The GRADE Working Group, 2009.
Shimada 1998
  • Shimada M, Takenaka K, Fujiwara Y, Gion T, Shirabe K, Yanaga K, et al. Risk factors linked to post operative morbidity in patients with hepatocellular carcinoma. British Journal of Surgery 1998;85:195-8.
Simonetti 1997
Song 2004
Starzl 1975
Thorlund 2009
  • Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses. International Journal of Epidemiology 2009;38(1):276-86.
Thorlund 2010
  • Thorlund K, Anema A, Mills E. Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. Clinical Epidemiology 2010;2:57-66.
Thorlund 2011
  • Thorlund K, Imberger G, Walsh M, Chu R, Gluud C, Wetterslev J, et al. The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study. PLoS One 2011;6(10):e25491.
Thorlund 2011a
  • Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). http://ctu.dk/tsa/files/tsa_manual.pdf 2011 (accessed 12 April 2012).
Tiribelli 1989
  • Tiribelli C, Melato M, Croce LS, Giarelli L, Okuda K, Ohnishi K. Prevalence of hepatocellular carcinoma and relation to cirrhosis: comparison of two different cities of the world - Trieste, Italy, and Chiba, Japan. Hepatology 1989;10(6):998-1002.
Tjandra 1991
Wetterslev 2008
  • Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61(1):64-75.
Wetterslev 2009
  • Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in a random-effects meta-analysis. BMC Medical Research Methodology 2009;9:86.
Wood 2008
  • Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.) 2008;336:601-5.
Yamamoto 1994
  • Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115:303–9.
Yeh 1989
  • Yeh F, Yu M, Mo C, Luo S, Tong M, Henderson B. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Research 1989;49:2506-9.
Yoshimura 2004
  • Yoshimura Y, Kubo S, Shirata K, Hirohashi K, Tanaka H, Shuto T, et al. Risk factors for postoperative delirium after liver resection for hepatocellular carcinoma. World Journal of Surgery 2004;28:982-6.